 |
PDBsum entry 1ntj
|
|
|
|
 |
|
|
|
|
|
|
|
 |
|
|
|
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
|
|
|
|
|
|
|
|
|
|
Immune system
|
PDB id
|
|
|
|
1ntj
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
References listed in PDB file
|
 |
|
Key reference
|
 |
|
Title
|
 |
The extended multidomain solution structures of the complement protein crry and its chimeric conjugate crry-Ig by scattering, Analytical ultracentrifugation and constrained modelling: implications for function and therapy.
|
 |
|
Authors
|
 |
M.Aslam,
J.M.Guthridge,
B.K.Hack,
R.J.Quigg,
V.M.Holers,
S.J.Perkins.
|
 |
|
Ref.
|
 |
J Mol Biol, 2003,
329,
525-550.
[DOI no: ]
|
 |
|
PubMed id
|
 |
|
 |
 |
|
Abstract
|
 |
|
Complement receptor-related gene/protein y (Crry) is a cell membrane-bound
regulator of complement activation found in mouse and rat. Crry contains only
short complement/consensus repeat (SCR) domains. X-ray and neutron scattering
was performed on recombinant rat Crry containing the first five SCR domains
(rCrry) and mouse Crry with five SCR domains conjugated to the Fc fragment of
mouse IgG1 (mCrry-Ig) in order to determine their solution structures at medium
resolution. The radius of gyration R(G) of rCrry was determined to be 4.9-5.0
nm, and the R(G) of the cross-section was 1.2-1.5 nm as determined by X-ray and
neutron scattering. The R(G) of mCrry-Ig was 6.6-6.7 nm, and the R(G) of the
cross-section were 2.3-2.4 nm and 1.3 nm. The maximum dimension of rCrry was 18
nm and that for mCrry-Ig was 26 nm. The neutron data indicated that rCrry and
mCrry-Ig have molecular mass values of 45,000 Da and 140,000 Da, respectively,
in agreement with their sequences, and sedimentation equilibrium data supported
these determinations. Time-derivative velocity experiments gave sedimentation
coefficients of 2.4S for rCrry and 5.4S for mCrry-Ig. A medium-resolution model
of rCrry was determined using homology models that were constructed for the
first five SCR domains of Crry from known crystal and NMR structures, and linked
by randomly generated linker peptide conformations. These trial-and-error
calculations revealed a small family of extended rCrry structures that best
accounted for the scattering and ultracentrifugation data. These were shorter
than the most extended rCrry models as the result of minor bends in the
inter-SCR orientations. The mCrry-Ig solution data were modelled starting from a
fixed structure for rCrry and the crystal structure of mouse IgG1, and was based
on conformational searches of the hinge peptide joining the mCrry and Fc
fragments. The best-fit models showed that the two mCrry antennae in mCrry-Ig
were extended from the Fc fragment. No preferred orientation of the antennae was
identified, and this indicated that the accessibility of the antennae for the
molecular targets C4b and C3b was not affected by the covalent link to Fc. A
structural comparison between Crry and complement receptor type 1 indicated that
the domain arrangement of Crry SCR 1-3 is as extended as that of the CR1 SCR
15-17 NMR structure.
|
 |
 |
 |
|
 |
|
 |
Figure 1.
Figure 1. SCR domain arrangement in rCrry and mCrry-Ig. The
location of the presumed N-linked glycosylation sites are
denoted by q symbols, and the number of linker residues between
adjacent domains is denoted by the numbers next to the linker in
question.
|
 |
Figure 8.
Figure 8. Ribbon views of 20 linker structures seen in
crystal and NMR structures of pairs of SCR domains. The most
common linker conformations are shown in yellow. Four linker
conformations that deviate from the most common ones are denoted
by green ribbons and labelled a to d. Four linkers that show
less conformational deviations are labelled w to z. The eight
residue and three residue linkers are shown in purple and red,
respectively. The left-hand view corresponds to the SCR-1
structure of b2GPI, in which the linkers are shown superimposed
at the C terminus at Cys58. The right-hand view corresponds to
the SCR-2 structure of b2GPI, in which the linkers are
superimposed at the N terminus at Cys4.
|
 |
|
 |
 |
|
The above figures are
reprinted
by permission from Elsevier:
J Mol Biol
(2003,
329,
525-550)
copyright 2003.
|
 |
|
|
|
|
|
Headers
|
 |
|
|
|
 |